Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Drop in Short Interest

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the recipient of a large decline in short interest in March. As of March 31st, there was short interest totalling 2,300 shares, a decline of 42.5% from the March 15th total of 4,000 shares. Based on an average daily trading volume, of 63,800 shares, the short-interest ratio is currently 0.0 days.

Ocean Biomedical Stock Down 31.6 %

NASDAQ:OCEAW opened at $0.02 on Thursday. The firm’s 50-day moving average price is $0.03 and its 200-day moving average price is $0.03. Ocean Biomedical has a 1-year low of $0.02 and a 1-year high of $0.18.

Ocean Biomedical Company Profile

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.